Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Meilin Möllenkamp"'
Publikováno v:
Health Economics. 31:157-178
We investigated the role of spillover effects among hospitals in the diffusion of drug-eluting stents (DES) in Germany and Italy during a period in which the relevant medical guideline clearly recommended their use over bare-metal stents. We used adm
Autor:
Oliver Rauprich, Meilin Möllenkamp, Jennifer Reimann, Stefan Huster, Jonas Schreyögg, Georg Marckmann
Publikováno v:
Das Gesundheitswesen. 84:1059-1066
Zusammenfassung Hintergrund Nudges bieten vielfältige Möglichkeiten zur Förderung von gesundheitsbezogenem Verhalten im Alltag, die klassische Public Health-Maßnahmen ergänzen können. Vor diesem Hintergrund führten wir vorläufige Untersuchung
Autor:
Stefan Rabbe, Meilin Möllenkamp, Benedetta Pongiglione, Hedwig Blommestein, Pim Wetzelaer, Renaud Heine, Jonas Schreyögg
Publikováno v:
Health Economics (United Kingdom), 31(S1), 135-156. John Wiley & Sons Ltd.
Variation in healthcare utilization has been discussed extensively, with many studies showing that variation exists, but fewer studies investigating the underlying factors. In our study, we used a logistic multilevel-model at the patient, hospital, a
Autor:
Saskia de Groot, Stefan Rabbe, Oriana Ciani, Carlo Federici, Meilin Möllenkamp, Bogdan Grigore, Florian Dams, Kosta Shatrov, Rodney J. Taylor, Antal Zemplényi
Publikováno v:
Grigore, Bogdan; Ciani, Oriana; Dams, Florian; Federici, Carlo; de Groot, Saskia; Möllenkamp, Meilin; Rabbe, Stefan; Shatrov, Kosta; Zemplenyi, Antal; Taylor, Rod S. (2020). Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. PharmacoEconomics, 38(10), pp. 1055-1070. Springer 10.1007/s40273-020-00935-1
PharmacoEconomics
Pharmacoeconomics (Print), 38, 1055-1070. Adis
PharmacoEconomics
Pharmacoeconomics (Print), 38, 1055-1070. Adis
In the drive towards faster patient access to treatments, health technology assessment (HTA) agencies are increasingly faced with reliance on evidence from surrogate endpoints, leading to increased decision uncertainty. This study undertook an update
Publikováno v:
Health Policy. 123:1199-1209
In this systematic literature review, we identify evidence on the effectiveness of nudges in improving the self-management of adults with chronic diseases and derive policy recommendations. We included empirical studies of any design published up to
Autor:
Saskia de Groot, Rudolf Blankart, Meilin Möllenkamp, Oriana Ciani, Aleksandra Torbica, Hedwig M. Blommestein, Michael Drummond, Benedetta Pongiglione, Sándor Kovács, Florian Dams, Sarah Walker, Rosanna Tarricone
Publikováno v:
Pongiglione, Benedetta; Torbica, Aleksandra; Blommestein, Hedwig; de Groot, Saskia; Ciani, Oriana; Walker, Sarah; Dams, Florian; Blankart, Rudolf; Mollenkamp, Meilin; Kovács, Sándor; Tarricone, Rosanna; Drummond, Mike (2021). Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal. International journal of technology assessment in health care, 37(1), e62. Cambridge University Press 10.1017/S0266462321000301
International Journal of Technology Assessment in Health Care, 37(1):e62. Cambridge University Press
International Journal of Technology Assessment in Health Care, 37(1):e62. Cambridge University Press
Aim Technological and computational advancements offer new tools for the collection and analysis of real-world data (RWD). Considering the substantial effort and resources devoted to collecting RWD, a greater return would be achieved if real-world ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0f909b49cba4c0d35f9f281ffa6b92
https://boris.unibe.ch/156240/1/do-existing-real-world-data-sources-generate-suitable-evidence-for-the-hta-of-medical-devices-in-europe-mapping-and-critical-appraisal.pdf
https://boris.unibe.ch/156240/1/do-existing-real-world-data-sources-generate-suitable-evidence-for-the-hta-of-medical-devices-in-europe-mapping-and-critical-appraisal.pdf
Autor:
Ciani, Oriana, Grigore, Bogdan, Blommestein, Hedwig, Groot, Saskia De, Meilin Möllenkamp, Rabbe, Stefan, Daubner-Bendes, Rita, Taylor, Rod S.
Supplemental material, sj-doc-1-mdm-10.1177_0272989X21994553 for Validity of Surrogate Endpoints and Their Impact on Coverage Recommendations: A Retrospective Analysis across International Health Technology Assessment Agencies by Oriana Ciani, Bogdan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f82f34c33eec7fa67fddbac88cc2bca
Autor:
Bogdan Grigore, Meilin Möllenkamp, Hedwig M. Blommestein, Saskia de Groot, Rod S Taylor, Rita Daubner-Bendes, Stefan Rabbe, Oriana Ciani
Publikováno v:
Medical Decision Making, 41(4), 439-452. SAGE Publishing
Medical Decision Making
Medical Decision Making
Background Surrogate endpoints (i.e., intermediate endpoints intended to predict for patient-centered outcomes) are increasingly common. However, little is known about how surrogate evidence is handled in the context of health technology assessment (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e165fdfe6d8f66bd316673e8fd5825
http://hdl.handle.net/11565/4038190
http://hdl.handle.net/11565/4038190